Abstract:The superfamily of G protein-coupled receptors (GPCRs) contains immense structural and functional diversity and mediates a myriad of biological processes upon activation by various extracellular signals. Critical roles of GPCRs have been established in bone development, remodeling, and disease. Multiple human GPCR mutations impair bone development or metabolism, resulting in osteopathologies. Here we summarize the disease phenotypes and dysfunctions caused by GPCR gene mutations in humans as well as by deletion in animals. To date, 92 receptors (5 glutamate family, 67 rhodopsin family, 5 adhesion, 4 frizzled/taste2 family, 5 secretin family, and 6 other 7TM receptors) have been associated with bone diseases and dysfunctions (36 in humans and 72 in animals). By analyzing data from these 92 GPCRs, we found that mutation or deletion of different individual GPCRs could induce similar bone diseases or dysfunctions, and the same individual GPCR mutation or deletion could induce different bone diseases or dysfunctions in different populations or animal models. Data from human diseases or dysfunctions identified 19 genes whose mutation was associated with human BMD: 9 genes each for human height and osteoporosis; 4 genes each for human osteoarthritis (OA) and fracture risk; and 2 genes each for adolescent idiopathic scoliosis (AIS), periodontitis, osteosarcoma growth, and tooth development. Reports from gene knockout animals found 40 GPCRs whose deficiency reduced bone mass, while deficiency of 22 GPCRs increased bone mass and BMD; deficiency of 8 GPCRs reduced body length, while 5 mice had reduced femur size upon GPCR deletion. Furthermore, deficiency in 6 GPCRs induced osteoporosis; 4 induced osteoarthritis; 3 delayed fracture healing; 3 reduced arthritis severity; and reduced bone strength, increased bone strength, and increased cortical thickness were each observed in 2 GPCR-deficiency models. The ever-expanding number of GPCR mutation-associated diseases warrants accelerated molecular analysis, population studies, and investigation of phenotype correlation with SNPs to elucidate GPCR function in human diseases.

LGR4: A New Receptor Member in Endocrine and Metabolic Diseases

G Protein and its signaling pathway in bone development and disease.

Emerging Roles for LGR4 in Organ Development, Energy Metabolism and Carcinogenesis

LGR4 is a receptor for RANKL and negatively regulates osteoclast differentiation and bone resorption

Lgr4 promotes aerobic glycolysis and differentiation in osteoblasts via the canonical Wnt/β ‐catenin pathway

LRP4 in Neuromuscular Junction and Bone Development and Diseases.

Lgr4 promotes aerobic glycolysis and differentiation in osteoblasts via the canonical Wnt/-catenin pathway

The Orphan Nuclear Receptor 4A1: A Potential New Therapeutic Target for Metabolic Diseases

The Roles of GRP81 As a Metabolic Sensor and Inflammatory Mediator

Disease-causing Mutation in GPR54 Reveals the Importance of the Second Intracellular Loop for Class A G-protein-coupled Receptor Function

The emerging roles of GPR158 in the regulation of the endocrine system

LGR4 Modulates Breast Cancer Initiation, Metastasis, and Cancer Stem Cells

Ablation of Lgr4 Enhances Energy Adaptation in Skeletal Muscle Via Activation of Ampk/Sirt1/Pgc1α Pathway.

Loss of Lgr4 Inhibits Differentiation, Migration and Apoptosis, and Promotes Proliferation in Bone Mesenchymal Stem Cells

The Pathophysiological Functions and Therapeutic Potential of GPR39: Focus on Agonists and Antagonists

The role of GPCRs in bone diseases and dysfunctions

Ablation of LGR4 promotes energy expenditure by driving white-to-brown fat switch

Lgr5 in cancer biology: functional identification of Lgr5 in cancer progression and potential opportunities for novel therapy

Lgr4 gene regulates corpus luteum maturation through modulation of the WNT-mediated EGFR-ERK signaling pathway.

Minireview: Pathophysiological Roles of the TR4 Nuclear Receptor: Lessons Learned from Mice Lacking TR4.

Biological characteristics and agonists of GPR120 (FFAR4) receptor: the present status of research